• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米工程化间充质干细胞向转移性乳腺癌细胞递送纳米颗粒

Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells.

作者信息

Saulite Liga, Pleiko Karlis, Popena Ineta, Dapkute Dominyka, Rotomskis Ricardas, Riekstina Una

机构信息

Faculty of Medicine, University of Latvia, Raina Blvd. 19, LV-1586 Riga, Latvia.

Biomedical Physics Laboratory, National Cancer Institute, P. Baublio Street 3b, LT-08406 Vilnius, Lithuania.

出版信息

Beilstein J Nanotechnol. 2018 Jan 29;9:321-332. doi: 10.3762/bjnano.9.32. eCollection 2018.

DOI:10.3762/bjnano.9.32
PMID:29515946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5815277/
Abstract

We created a 3D cell co-culture model by combining nanoengineered mesenchymal stem cells (MSCs) with the metastatic breast cancer cell line MDA-MD-231 and primary breast cancer cell line MCF7 to explore the transfer of quantum dots (QDs) to cancer cells. First, the optimal conditions for high-content QD loading in MSCs were established. Then, QD uptake in breast cancer cells was assessed after 24 h in a 3D co-culture with nanoengineered MSCs. We found that incubation of MSCs with QDs in a serum-free medium provided the best accumulation results. It was found that 24 h post-labelling QDs were eliminated from MSCs. Our results demonstrate that breast cancer cells efficiently uptake QDs that are released from nanoengineered MSCs in a 3D co-culture. Moreover, the uptake is considerably enhanced in metastatic MDA-MB-231 cells compared with MCF7 primary breast cancer cells. Our findings suggest that nanoengineered MSCs could serve as a vehicle for targeted drug delivery to metastatic cancer.

摘要

我们通过将纳米工程化间充质干细胞(MSCs)与转移性乳腺癌细胞系MDA-MD-231和原发性乳腺癌细胞系MCF7相结合,创建了一个3D细胞共培养模型,以探索量子点(QDs)向癌细胞的转移。首先,确定了MSCs中高含量QD负载的最佳条件。然后,在与纳米工程化MSCs进行3D共培养24小时后,评估乳腺癌细胞对QD的摄取情况。我们发现,在无血清培养基中用QD孵育MSCs可提供最佳的积累结果。结果发现,标记后24小时,QD从MSCs中被清除。我们的结果表明,在3D共培养中,乳腺癌细胞能有效摄取从纳米工程化MSCs释放的QD。此外,与MCF7原发性乳腺癌细胞相比,转移性MDA-MB-231细胞中的摄取显著增强。我们的研究结果表明,纳米工程化MSCs可作为向转移性癌症进行靶向药物递送的载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/61d87a7695b9/Beilstein_J_Nanotechnol-09-321-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/c3a999f957c3/Beilstein_J_Nanotechnol-09-321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/588e40fc8a02/Beilstein_J_Nanotechnol-09-321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/039f691bb908/Beilstein_J_Nanotechnol-09-321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/d1de13cd0c6b/Beilstein_J_Nanotechnol-09-321-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/a3a6d07f77f8/Beilstein_J_Nanotechnol-09-321-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/5b91e476c3de/Beilstein_J_Nanotechnol-09-321-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/61d87a7695b9/Beilstein_J_Nanotechnol-09-321-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/c3a999f957c3/Beilstein_J_Nanotechnol-09-321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/588e40fc8a02/Beilstein_J_Nanotechnol-09-321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/039f691bb908/Beilstein_J_Nanotechnol-09-321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/d1de13cd0c6b/Beilstein_J_Nanotechnol-09-321-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/a3a6d07f77f8/Beilstein_J_Nanotechnol-09-321-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/5b91e476c3de/Beilstein_J_Nanotechnol-09-321-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7644/5815277/61d87a7695b9/Beilstein_J_Nanotechnol-09-321-g008.jpg

相似文献

1
Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells.纳米工程化间充质干细胞向转移性乳腺癌细胞递送纳米颗粒
Beilstein J Nanotechnol. 2018 Jan 29;9:321-332. doi: 10.3762/bjnano.9.32. eCollection 2018.
2
Skin-derived mesenchymal stem cells as quantum dot vehicles to tumors.皮肤来源的间充质干细胞作为肿瘤的量子点载体。
Int J Nanomedicine. 2017 Nov 6;12:8129-8142. doi: 10.2147/IJN.S143367. eCollection 2017.
3
Persistence of fluorescent nanoparticle-labelled bone marrow mesenchymal stem cells in vitro and after intra-articular injection.荧光纳米颗粒标记骨髓间充质干细胞在体外和关节内注射后的持久性。
J Tissue Eng Regen Med. 2019 Feb;13(2):191-202. doi: 10.1002/term.2781. Epub 2019 Jan 23.
4
Nano-engineered skin mesenchymal stem cells: potential vehicles for tumour-targeted quantum-dot delivery.纳米工程化皮肤间充质干细胞:肿瘤靶向量子点递送的潜在载体
Beilstein J Nanotechnol. 2017 Jun 7;8:1218-1230. doi: 10.3762/bjnano.8.123. eCollection 2017.
5
Polyamidoamine dendrimer-conjugated quantum dots for efficient labeling of primary cultured mesenchymal stem cells.聚酰胺-胺树枝状聚合物偶联量子点用于原代培养间充质干细胞的高效标记。
Biomaterials. 2011 Oct;32(28):6676-82. doi: 10.1016/j.biomaterials.2011.05.076. Epub 2011 Jun 22.
6
Determining Conditions for Successful Culture of Multi-Cellular 3D Tumour Spheroids to Investigate the Effect of Mesenchymal Stem Cells on Breast Cancer Cell Invasiveness.确定成功培养多细胞3D肿瘤球体的条件,以研究间充质干细胞对乳腺癌细胞侵袭性的影响。
Bioengineering (Basel). 2019 Nov 1;6(4):101. doi: 10.3390/bioengineering6040101.
7
Quantum dot labeling of mesenchymal stem cells.量子点标记间充质干细胞。
J Nanobiotechnology. 2007 Nov 7;5:9. doi: 10.1186/1477-3155-5-9.
8
Chitosan-hyaluronan based 3D co-culture platform for studying the crosstalk of lung cancer cells and mesenchymal stem cells.基于壳聚糖-透明质酸的3D共培养平台用于研究肺癌细胞与间充质干细胞的相互作用。
Acta Biomater. 2016 Sep 15;42:157-167. doi: 10.1016/j.actbio.2016.06.014. Epub 2016 Jun 11.
9
Functional quantum dot-siRNA nanoplexes to regulate chondrogenic differentiation of mesenchymal stem cells.用于调节间充质干细胞软骨分化的功能性量子点-siRNA纳米复合物
Acta Biomater. 2016 Dec;46:165-176. doi: 10.1016/j.actbio.2016.09.008. Epub 2016 Sep 9.
10
Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.封装人间质干细胞(eMSCs)作为一种新型的针对乳腺癌干细胞的抗癌药物:3D 预刺激治疗性 MSCs 的开发。
Int J Biochem Cell Biol. 2019 May;110:59-69. doi: 10.1016/j.biocel.2019.02.001. Epub 2019 Feb 6.

引用本文的文献

1
Applicability of Quantum Dots in Breast Cancer Diagnostic and Therapeutic Modalities-A State-of-the-Art Review.量子点在乳腺癌诊断与治疗方式中的适用性——最新综述
Nanomaterials (Basel). 2024 Aug 31;14(17):1424. doi: 10.3390/nano14171424.
2
Lipid-based nanosystems: the next generation of cancer immune therapy.基于脂质的纳米系统:下一代癌症免疫治疗。
J Hematol Oncol. 2024 Jul 19;17(1):53. doi: 10.1186/s13045-024-01574-1.
3
Roles of Mesenchymal Stem Cells in Breast Cancer Therapy: Engineered Stem Cells and Exosomal Cell-Free Based Therapy.

本文引用的文献

1
Skin-derived mesenchymal stem cells as quantum dot vehicles to tumors.皮肤来源的间充质干细胞作为肿瘤的量子点载体。
Int J Nanomedicine. 2017 Nov 6;12:8129-8142. doi: 10.2147/IJN.S143367. eCollection 2017.
2
Nano-engineered skin mesenchymal stem cells: potential vehicles for tumour-targeted quantum-dot delivery.纳米工程化皮肤间充质干细胞:肿瘤靶向量子点递送的潜在载体
Beilstein J Nanotechnol. 2017 Jun 7;8:1218-1230. doi: 10.3762/bjnano.8.123. eCollection 2017.
3
The Reproductive Toxicity of CdSe/ZnS Quantum Dots on the in vivo Ovarian Function and in vitro Fertilization.
间充质干细胞在乳腺癌治疗中的作用:工程化干细胞与基于外泌体的无细胞疗法
Curr Mol Med. 2025;25(4):431-444. doi: 10.2174/0115665240274818231207054037.
4
Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle.异种马源干细胞在基于 4T1 的三阴性乳腺癌管内小鼠模型中激活抗肿瘤适应性免疫:原理验证。
Front Immunol. 2023 Oct 20;14:1252374. doi: 10.3389/fimmu.2023.1252374. eCollection 2023.
5
The Therapeutic Effects of Mesenchymal Stem Cells and their Secretome on Oral Squamous Cell Carcinoma.间充质干细胞及其分泌组治疗口腔鳞状细胞癌的疗效。
Curr Mol Med. 2024;24(10):1195-1207. doi: 10.2174/1566524023666230627151809.
6
Quantum Dots Mediated Imaging and Phototherapy in Cancer Spheroid Models: State of the Art and Perspectives.量子点介导的癌症球体模型成像与光疗:现状与展望
Pharmaceutics. 2022 Oct 8;14(10):2136. doi: 10.3390/pharmaceutics14102136.
7
Breast Cancer Therapy: The Potential Role of Mesenchymal Stem Cells in Translational Biomedical Research.乳腺癌治疗:间充质干细胞在转化生物医学研究中的潜在作用
Biomedicines. 2022 May 19;10(5):1179. doi: 10.3390/biomedicines10051179.
8
Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend.癌症治疗中的间充质干细胞:化敌为友的艺术。
Iran J Basic Med Sci. 2021 Oct;24(10):1307-1323. doi: 10.22038/IJBMS.2021.58227.12934.
9
Nephrotoxicity Evaluation of Indium Phosphide Quantum Dots with Different Surface Modifications in BALB/c Mice.不同表面修饰的磷化铟量子点在 BALB/c 小鼠中的肾毒性评价。
Int J Mol Sci. 2020 Sep 27;21(19):7137. doi: 10.3390/ijms21197137.
10
Nanoparticles Targeting STATs in Cancer Therapy.纳米颗粒在癌症治疗中靶向 STATs。
Cells. 2019 Sep 27;8(10):1158. doi: 10.3390/cells8101158.
CdSe/ZnS 量子点对体内卵巢功能和体外受精的生殖毒性。
Sci Rep. 2016 Nov 23;6:37677. doi: 10.1038/srep37677.
4
Genetically modified mesenchymal stromal cells in cancer therapy.癌症治疗中的基因改造间充质基质细胞。
Cytotherapy. 2016 Nov;18(11):1435-1445. doi: 10.1016/j.jcyt.2016.09.003.
5
Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy.基于组合纳米载体的药物传递方法在乳腺癌细胞中联合应用抗肿瘤药物:一种改进的纳米医学策略。
Sci Rep. 2016 Oct 11;6:34053. doi: 10.1038/srep34053.
6
Interaction of MSC with tumor cells.间充质干细胞与肿瘤细胞的相互作用。
Cell Commun Signal. 2016 Sep 8;14(1):20. doi: 10.1186/s12964-016-0143-0.
7
Mesenchymal stem cells as delivery vectors for anti-tumor therapy.间充质干细胞作为抗肿瘤治疗的递送载体
Stem Cell Investig. 2015 Mar 26;2:6. doi: 10.3978/j.issn.2306-9759.2015.03.01. eCollection 2015.
8
Protein Profiles Associated with Anoikis Resistance of Metastatic MDA-MB-231 Breast Cancer Cells.与转移性MDA-MB-231乳腺癌细胞失巢凋亡抗性相关的蛋白质谱
Asian Pac J Cancer Prev. 2016;17(2):581-90. doi: 10.7314/apjcp.2016.17.2.581.
9
In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform.体外肿瘤模型:优缺点、变量以及正确平台的选择。
Front Bioeng Biotechnol. 2016 Feb 12;4:12. doi: 10.3389/fbioe.2016.00012. eCollection 2016.
10
3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained.用于体外治疗筛选的3D肿瘤球体模型:一种增强所获数据生物学相关性的系统方法。
Sci Rep. 2016 Jan 11;6:19103. doi: 10.1038/srep19103.